Keywords
Atrial Fibrillation ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

196 Search results.

Eligibility Persistent Atrial Fibrillation NCT02509754

- 6/13/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function; ODM derived from: https://clinicaltrials.gov/show/NCT02509754

Eligibility Persistent Atrial Fibrillation NCT02344394

- 6/12/19 - 1 form, 2 itemgroups, 21 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prospective, Randomized Comparison of Hybrid Ablation vs. Catheter Ablation (PRHACA); ODM derived from: https://clinicaltrials.gov/show/NCT02344394

Eligibility Persistent Atrial Fibrillation NCT02234102

- 6/12/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT02234102

External Event Recorders in Atrial Fibrillation NCT00863382 - Eligibility Criteria

- 5/14/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of External Event Recorders for Atrial Fibrillation Monitoring; ODM derived from: https://clinicaltrials.gov/show/NCT00863382 Brief Summary: Ablation of atrial fibrillation is a well established treatment method to restore normal sinus rhythm and eliminate the need for continued antiarrhythmic therapy and anticoagulation. Absence of symptomatic and asymptomatic atrial fibrillation should be considered necessary for discontinuation of anticoagulation therapy. Presently, recurrence of atrial fibrillation is usually determined with the use of a non looping event monitor which is typically used by the subject at the time of symptomatic arrhythmia. This method does not detect asymptomatic atrial fibrillation. Random asymptomatic recording can be added, but the chance for detecting recurrence of arrhythmia is not great. Too frequently, the success rates of AF ablation procedures are inflated by insufficient follow up and patient's limited compliance in reporting and recording episodes of recurrent arrhythmias. Often times, it is very inconvenient for patients to wear external event recorders. Allergies to the sticky pads that are needed for most of the external monitoring devices continues to be a problem. Implantable loop recorders have the advantage of detecting symptomatic and asymptomatic atrial fibrillation continuously. They also offer the convenience of monitoring for up to 18 to 24 months without significant patient discomfort. However, implantation and explantation of these devices involves a limited surgical procedure as well as considerable experience. In this study we attempt to assess the differences in these two types of monitoring systems in assessing the long term efficacy of AF ablation.

Eligibility Atrial Fibrillation NCT02506244

- 1/31/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
mHealth Screening to Prevent Strokes; ODM derived from: https://clinicaltrials.gov/show/NCT02506244

Eligibility Atrial Fibrillation NCT02498769

- 1/31/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02498769

Eligibility Atrial Fibrillation NCT02497248

- 1/31/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance; ODM derived from: https://clinicaltrials.gov/show/NCT02497248

Eligibility Atrial Fibrillation NCT02493075

- 1/31/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population; ODM derived from: https://clinicaltrials.gov/show/NCT02493075

Eligibility Atrial Fibrillation NCT02485925

- 1/31/19 - 1 form, 2 itemgroups, 34 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SMART China, A Multi-center Clinical Registry Study; ODM derived from: https://clinicaltrials.gov/show/NCT02485925

Eligibility Atrial Fibrillation NCT02478294

- 1/30/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison Between Thoracoscopic Left Atrial Appendage Excision and Warfarin for the Secondary Prevention of Stroke in Patients With AF; ODM derived from: https://clinicaltrials.gov/show/NCT02478294

Eligibility Atrial Fibrillation NCT02463851

- 1/30/19 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT02463851

Eligibility Atrial Fibrillation NCT02461602

- 1/30/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02461602